Physician profile
John G Jarrett
NPI 1336198761
$1,235.10
in general payments reported to CMS, 2019-2025
11 companies · $213 in 2025
The $213 reported for 2025 was more than what a typical Reproductive Endocrinology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $56.71 · 2021: $90.49 · 2022: $335 · 2023: $198 · 2024: $151 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $459.97 | 2019-2023 | |
| Ferring Pharmaceuticals INC. | $266.20 | 2019-2025 | Menopur |
| Sumitomo Pharma America, INC. | $167.15 | 2023-2024 | Myfembree |
| Organon LLC | $115.70 | 2022-2025 | Ganirelix Acetate, Follistim Aq, Pregnyl |
| Coopersurgical, INC. | $78.80 | 2020-2025 | Stripper |
| Hologic Sales and Service, LLC | $61.81 | 2022-2024 | Myosure Tissue Removal Device, Omni Hysteroscope, Fluent Fluid Management System |
| Myovant Sciences INC. | $27.66 | 2022 | |
| Astellas Pharma US INC | $19.82 | 2025 | Veozah |
| Emd Serono, INC. | $12.82 | 2022 | |
| Merck Sharp & Dohme LLC | $12.69 | 2019 | |
| Covidien LP | $12.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Jarrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.